Liu B, et al. - The technical feasibility and treatment results of ultrasound (US)-guided percutaneous radiofrequency ablation (RFA) combined with ethanol ablation (EA) for hepatocellular carcinoma (HCC) were investigated by researchers in the caudate lobe. The eligible candidates included 49 patients with HCC in the caudate lobe underwent ablation From October 2009 to June 2016. Findings reported that HCCs in the RFA-EA group were larger compared to those in the EA-alone group. No major variations were found in the local tumour progression (LTP), disease-free survival (DFS), and overall survival rates between the RFA-EA group and RFA-alone or EA groups. It was deduced that US-guided percutaneous RFA-EA was a feasible and effective ththerapy for HCC in the caudate lobe.